Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice

Hypertension

Volumn 66, Issue 4, 2015, Pages 836-842

  Yiannikouris, Frederique ^a   Wang, Yu ^a   Shoemaker, Robin ^a   Larian, Nika ^a   Thompson, Joel ^b   English, Victoria L ^a   Charnigo, Richard ^b   Su, Wen ^b   Gong, Ming ^b   Cassis, Lisa A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

angiotensinogen; blood pressure; liver; obesity

Indexed keywords

ALBUMIN; ANGIOTENSIN II; ANGIOTENSINOGEN; CRE RECOMBINASE; MEGALIN; MESSENGER RNA;

ADIPOCYTE; ADIPOSE TISSUE; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; EXPLANT; FEMALE; HORMONE DEFICIENCY; HYPERTENSION; LEAN BODY WEIGHT; LIPID DIET; LIVER CELL; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN; ANIMAL; BODY WEIGHT; C57BL MOUSE; CELL CULTURE; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ANGIOTENSINOGEN; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HEPATOCYTES; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; RNA, MESSENGER; THINNESS;

EID: 84941216127     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06040     Document Type: Article

References (26)

1. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ, Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008 52 818 827. doi: 10.1161/HYPERTENSIONAHA.108.113357
2. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA, Activation of the systemic and adipose renin-Angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004 287 R943 R949. doi: 10.1152/ajpregu.00265.2004
3. Gupte M, Boustany-Kari CM, Bharadwaj K, Police S, Thatcher S, Gong MC, English VL, Cassis LA, ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol 2008 295 R781 R788. doi: 10.1152/ajpregu.00183.2008
4. Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G, Mechanisms of obesity-induced hypertension. Hypertens Res 2010 33 386 393. doi: 10.1038/hr.2010.9
5. Licata G, Corrao S, Parrinello G, Scaglione R, Obesity and cardiovascular diseases. Ann Ital Med Int 1994 9 27 31
6. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M, Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997 10 629 633
7. Yiannikouris F, Gupte M, Putnam K, Cassis L, Adipokines and blood pressure control. Curr Opin Nephrol Hypertens 2010 19 195 200. doi: 10.1097/MNH.0b013e3283366cd0
8. Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH, Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am J Hypertens 2011 24 383 391. doi: 10.1038/ajh.2010.217
9. Huang SS, Wu TC, Lin SJ, Chen JW, Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension. Circ J 2009 73 2282 2287
10. Kolasinska-Malkowska K, Filipiak KJ, Gwizdala A, Tykarski A, Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications. Expert Rev Cardiovasc Ther 2008 6 759 771. doi: 10.1586/14779072.6.5.759
11. Koren G, Hypertension: ACE inhibitor use in pregnancy-setting the record straight. Nat Rev Cardiol 2012 9 7 8. doi: 10.1038/nrcardio.2011.179
12. Peck RN, Smart LR, Beier R, Liwa AC, Grosskurth H, Fitzgerald DW, Schmidt BM, Difference in blood pressure response to ACE-Inhibitor monotherapy between black and white adults with arterial hypertension: a meta-Analysis of 13 clinical trials. BMC Nephrol 2013 14 201. doi: 10.1186/1471-2369-14-201
13. Vershinina AM, Gapon LI, Veber EE, Popova SN, Pliusnin AV, Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia. Ter Arkh 2005 77 55 58
14. Mori Y, Tanaka T, Matsuura K, Yokoyama J, Utsunomiya K, Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE). Adv Ther 2011 28 698 706. doi: 10.1007/s12325-011-0040-2
15. Tamura K, Umemura S, Sumida Y, Nyui N, Kobayashi S, Ishigami T, Kihara M, Sugaya T, Fukamizu A, Miyazaki H, Murakami K, Ishii M, Effect of genetic deficiency of angiotensinogen on the renin-Angiotensin system. Hypertension 1998 32 223 227
16. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K, Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994 269 31334 31337
17. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I, Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 2012 23 1181 1189. doi: 10.1681/ASN.2011121159
18. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel JM, Elements of a paracrine tubular renin-Angiotensin system along the entire nephron. Hypertension 1999 34 1265 1274
19. Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, Bachmann S, Theilig F, Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 2010 285 41935 41946. doi: 10.1074/jbc.M110.150284
20. Yiannikouris F, Karounos M, Charnigo R, English VL, Rateri DL, Daugherty A, Cassis LA, Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol 2012 302 R244 R251. doi: 10.1152/ajpregu.00323.2011
21. Kim S, Urs S, Massiera F, Wortmann P, Joshi R, Heo YR, Andersen B, Kobayashi H, Teboul M, Ailhaud G, Quignard-Boulangé A, Fukamizu A, Jones BH, Kim JH, Moustaid-Moussa N, Effects of high-fat diet, angiotensinogen (AGT) gene inactivation, and targeted expression to adipose tissue on lipid metabolism and renal gene expression. Horm Metab Res 2002 34 721 725. doi: 10.1055/s-2002-38263
22. Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M, Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001 15 2727 2729. doi: 10.1096/fj.01-0457fje
23. Massiera F, Seydoux J, Geloen A, Quignard-Boulange A, Turban S, Saint-Marc P, Fukamizu A, Negrel R, Ailhaud G, Teboul M, Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 2001 142 5220 5225. doi: 10.1210/endo.142.12.8556
24. Yiannikouris F, Gupte M, Putnam K, Thatcher S, Charnigo R, Rateri DL, Daugherty A, Cassis LA, Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 2012 60 1524 1530. doi: 10.1161/HYPERTENSIONAHA.112.192690
25. Cassis LA, Lynch KR, Peach MJ, Localization of angiotensinogen messenger RNA in rat aorta. Circ Res 1988 62 1259 1262
26. Hall JE, The kidney, hypertension, and obesity. Hypertension 2003 41 3 pt 2 625 633. doi: 10.1161/01.HYP.0000052314.95497.78